Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19.

Infection - 1 Apr 2024

Esmaeilzadeh Abdolreza, Ebrahimi Fereshteh, Jahani Maleki Armin, Siahmansouri Amir

Abstract excerpt

BACKGROUND: The World Health Organization announced the end of the Coronavirus Disease of 2019 (COVID-19) global health emergency on May 5, 2023. However, the reports from different countries indicate an elevation in the number of COVID-19-related hospitalizations and deaths through the last months. The subvariant XBB.1.5 (Kraken) was the cause of 49.1% of COVID-19 cases by the end of January 2023. Although, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to Hospitalization
Share to Immune Evasion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to SARS-CoV-2

Source

Identifiers

PMID: 38170417
DOI: 10.1007/s15010-023-02146-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19.PMID 38170417Read ↗

Emerging Omicron Subvariants EG.5 and BA.2.86: Implications for COVID-19 Immunity and SurveillanceSemantic proximity Read ↗

Emerging Omicron Subvariants EG.5 and BA.2.86: Implications for COVID-19 Immunity and SurveillanceSemantic proximity Read ↗

The omicron BA.2.86 subvariant as a new serotype of SARS-CoV-2Semantic proximity Read ↗

Omicron - The new SARS-CoV-2 challenge?Semantic proximity Read ↗

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variantSemantic proximity Read ↗

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies.Semantic proximity Read ↗

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant VariantSemantic proximity Read ↗

Title of the article: Current Review of the SARS-CoV-2 Omicron Subvariant BF.7 (BA.5.2.1.7) Virology and Preventing Strategies.Semantic proximity Read ↗

Virological characteristics of the SARS‐CoV‐2 Omicron EG.5.1 variantSemantic proximity Read ↗

Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters.Semantic proximity Read ↗

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionSemantic proximity Read ↗

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.